Specifically, kaempferol causes a blockage in the G2/M phase of human ovarian cancer cells by means of the Chk2/Cdc25C/Cdc2 pathway and the Chk2/p21/Cdc2 pathway. This evidence concerns the gene CDKN1A and ovarian cancer.